Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU
- PMID: 22301191
- DOI: 10.1016/j.bbrc.2012.01.049
Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU
Abstract
In this study, we investigate an anti-mitotic potential of the novel synthetic coumarin-based compound, 7-diethylamino-3(2'-benzoxazolyl)-coumarin, in 5-fluorouracil-resistant human gastric cancer cell line SNU-620-5FU and its parental cell SNU-620. It exerts the anti-proliferative effects with similar potencies against both cancer cells, which is mediated by destabilization of microtubules and subsequent mitotic arrest. Furthermore, this compound enhances caspase-dependent apoptotic cell death via decreased expression of anti-apoptotic genes. Taken together, our data strongly support anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin against drug-resistant cancer cells which will prompt us to further develop as a novel microtubule inhibitor for drug-resistant cancer chemotherapy.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.Biochem Pharmacol. 2009 Jun 15;77(12):1773-9. doi: 10.1016/j.bcp.2009.03.007. Epub 2009 Mar 19. Biochem Pharmacol. 2009. PMID: 19428332
-
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.Anticancer Drugs. 2010 Mar;21(3):270-6. doi: 10.1097/CAD.0b013e328334562c. Anticancer Drugs. 2010. PMID: 20023572
-
Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.Mol Cancer. 2006 May 18;5:20. doi: 10.1186/1476-4598-5-20. Mol Cancer. 2006. PMID: 16709241 Free PMC article.
-
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.Cancer Res. 2005 Apr 15;65(8):3162-70. doi: 10.1158/0008-5472.CAN-04-3300. Cancer Res. 2005. PMID: 15833846
-
The relationship between tumor metabolism and 5-fluorouracil resistance.Biochem Pharmacol. 2023 Dec;218:115902. doi: 10.1016/j.bcp.2023.115902. Epub 2023 Nov 1. Biochem Pharmacol. 2023. PMID: 37922975 Review. No abstract available.
Cited by
-
Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206.Biomed Res Int. 2014;2014:295760. doi: 10.1155/2014/295760. Epub 2014 Jul 8. Biomed Res Int. 2014. PMID: 25114899 Free PMC article.
-
Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.Cancer Biol Ther. 2012 Dec;13(14):1407-16. doi: 10.4161/cbt.22001. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954702 Free PMC article.
-
Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?Front Oncol. 2021 Oct 11;11:752784. doi: 10.3389/fonc.2021.752784. eCollection 2021. Front Oncol. 2021. PMID: 34707995 Free PMC article. Review.
-
Low amount of salinomycin greatly increases Akt activation, but reduces activated p70S6K levels.Int J Mol Sci. 2013 Aug 22;14(9):17304-18. doi: 10.3390/ijms140917304. Int J Mol Sci. 2013. PMID: 23975168 Free PMC article.
-
Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action.Cytotechnology. 2013 Aug;65(4):597-608. doi: 10.1007/s10616-012-9513-7. Epub 2012 Nov 16. Cytotechnology. 2013. PMID: 23161221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical